High Dose Ascorbic Acid for Plasma Cell Disorders

Clinical trial NCT03602235 · COMPLETED

Trial details

NCT number: NCT03602235
Sponsor: Christopher Strouse
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2019-03-05
Primary completion: 2024-07-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.